Summary of Study Design for CT-996: The study is a Phase 1 clinical trial, multi-centered and randomized where the goal is to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CT-996 in overweight or obese individuals as well as patients with Type 2 Diabetes Mellitus (T2DM)
In a letter to the CEO of Novo Nordisk, Sanders contends that Novo charges Americans with obesity $1,349 a month for Wegovy, while this same exact product can be purchased for just $140 in Germany and $92 in the U.K
GLP-1s are an emerging and powerful tool, but work alongside thoughtful, individualized, and proper nutrition
Oxidative stress in pulmonary fibrosis: A possible role for redox modulatory therapy
Potential Risks and Side Effects of Moringa Risks In countries where people eat fresh moringa, they cook the leaves like spinach, says Stacie Stephenson, a functional and integrative medicine practitioner and founder and CEO of health and wellness media venture VibrantDoc